Literature DB >> 2714164

Lower-extremity amputation in people with diabetes. Epidemiology and prevention.

D E Bild1, J V Selby, P Sinnock, W S Browner, P Braveman, J A Showstack.   

Abstract

The age-adjusted rate of lower-extremity amputation (LEA) in the diabetic population is approximately 15 times that of the nondiabetic population. Over 50,000 LEAs were performed on individuals with diabetes in the United States in 1985. Among individuals with diabetes, peripheral neuropathy and peripheral vascular disease (PVD) are major predisposing factors for LEA. Lack of adequate foot care and infection are additional risk factors. Several large clinical centers have experienced a 44-85% reduction in the rate of amputations among individuals with diabetes after the implementation of improved foot-care programs. Programs to reduce amputations among people with diabetes in primary-care settings should identify those at high risk; clinically evaluate individuals to determine specific risk status; ensure appropriate preventive therapy, treatment for foot problems, and follow-up; provide patient education; and, when necessary, refer patients to specialists, including health-care professionals for diagnostic and therapeutic interventions and shoe fitters for proper footwear. Programs should monitor and evaluate their activities and outcomes. Many issues related to the etiology and prevention of LEAs require further research.

Entities:  

Mesh:

Year:  1989        PMID: 2714164     DOI: 10.2337/diacare.12.1.24

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  57 in total

Review 1.  Cost-effective management of diabetic foot ulcers. A review.

Authors:  G Ragnarson-Tennvall; J Apelqvist
Journal:  Pharmacoeconomics       Date:  1997-07       Impact factor: 4.981

Review 2.  Diabetes mellitus.

Authors:  A B Johnson; R Taylor
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

3.  Can the use of a topical antifungal nail lacquer reduce risk for diabetic foot ulceration? Results from a randomised controlled pilot study.

Authors:  David G Armstrong; Katherine Holtz; Stephanie Wu
Journal:  Int Wound J       Date:  2005-06       Impact factor: 3.315

4.  How effective is systematic care of diabetic patients? A study in one general practice.

Authors:  M Koperski
Journal:  Br J Gen Pract       Date:  1992-12       Impact factor: 5.386

Review 5.  Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis.

Authors:  Joe F Lau; Mitchell D Weinberg; Jeffrey W Olin
Journal:  Nat Rev Cardiol       Date:  2011-05-31       Impact factor: 32.419

Review 6.  Screening, prevention, counseling, and treatment for the complications of type II diabetes mellitus. Putting evidence into practice.

Authors:  S Vijan; D L Stevens; W H Herman; M M Funnell; C J Standiford
Journal:  J Gen Intern Med       Date:  1997-09       Impact factor: 5.128

7.  Type 2 diabetes in family practice. Room for improvement.

Authors:  Stewart B Harris; Moira Stewart; Judith Belle Brown; Stephen Wetmore; Catherine Faulds; Susan Webster-Bogaert; Sheila Porter
Journal:  Can Fam Physician       Date:  2003-06       Impact factor: 3.275

8.  Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty.

Authors:  Satinder Singh; Ehrin J Armstrong; Walid Sherif; Bejan Alvandi; Gregory G Westin; Gagan D Singh; Ezra A Amsterdam; John R Laird
Journal:  Vasc Med       Date:  2014-06-17       Impact factor: 3.239

9.  Gallium maltolate treatment eradicates Pseudomonas aeruginosa infection in thermally injured mice.

Authors:  Katrina DeLeon; Fredrik Balldin; Chase Watters; Abdul Hamood; John Griswold; Sunil Sreedharan; Kendra P Rumbaugh
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

10.  Implementation of diabetic foot ulcer classification system for research purposes to predict lower extremity amputation.

Authors:  Abubakr H Widatalla; Seif Eidin I Mahadi; Mohamed A Shawer; Hagir A Elsayem; Mohamed E Ahmed
Journal:  Int J Diabetes Dev Ctries       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.